Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma NCT03719105 NK-Cell Lymphom...
NK-Cell Leukemi...
Peripheral T Ce...
Methotrexate
pralatraxate,
Ifosfamide
Dexamethasone
Etoposide
calaspargase pe...
cyclophosphamid...
Doxorubicin
Prednisone
Brentuximab Ved...
1 Year - 31 Years New York Medical College View Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) NCT06210750 T Acute Lymphob...
T Lymphoblastic...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Calaspargase Pe...
Computed Tomogr...
Cyclophosphamid...
Cytarabine
Daunorubicin
Dexamethasone
Doxorubicin
Echocardiograph...
Lumbar Puncture
Mercaptopurine
Methotrexate
Multigated Acqu...
Navitoclax
Nelarabine
Pegaspargase
Positron Emissi...
Thioguanine
Venetoclax
Vincristine
X-Ray Imaging
18 Years - 60 Years National Cancer Institute (NCI) View Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia NCT02981628 Recurrent B Acu...
Recurrent B Lym...
Refractory B Ac...
Refractory B Ly...
Asparaginase Er...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Diagnostic Imag...
Inotuzumab Ozog...
Leucovorin Calc...
Lumbar Puncture
Methotrexate
Pegaspargase
Vincristine
1 Year - 21 Years Children's Oncology Group View A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia NCT05761171 Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cytarabine
Echocardiograph...
Fludarabine Pho...
Hydrocortisone ...
Lumbar Puncture
Methotrexate
Multigated Acqu...
Prednisolone
Prednisone
Revumenib
Vincristine Sul...
1 Month - 6 Years Children's Oncology Group View Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664 Myelodysplastic...
Myelodysplastic...
Myelodysplastic...
Treatment-Relat...
Therapy-Related...
Acute Lymphobla...
Acute Lymphobla...
Lymphoblastic L...
Lymphoblastic L...
Acute Leukemia ...
Acute Leukemia ...
Venetoclax
Azacitidine
Cytarabine
Methotrexate
Hydrocortisone
Leucovorin
Dexamethasone
Vincristine
Doxorubicin
Dexrazoxane
Calaspargase Pe...
Erwinia asparag...
1 Year - 40 Years Dana-Farber Cancer Institute View Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma NCT03117751 Acute Lymphobla...
Acute Lymphobla...
Prednisone
Vincristine
Daunorubicin
Pegaspargase
Erwinase®
Cyclophosphamid...
Cytarabine
Mercaptopurine
Dasatinib
Methotrexate
Blinatumomab
Ruxolitinib
Bortezomib
Dexamethasone
Doxorubicin
Etoposide
Clofarabine
Vorinostat
Idarubicin
Nelarabine
Thioguanine
Asparaginase Er...
Calaspargase Pe...
1 Year - 18 Years St. Jude Children's Research Hospital View A Study Comparing the Combination of Dasatinib and Chemotherapy Treatment With or Without Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or Philadelphia Chromosome-Like (Ph-Like) ABL-Class B-Cell Acute Lymphoblastic Leukemia (B-ALL) NCT06124157 B Acute Lymphob...
Biospecimen Col...
Blinatumomab
Bone Marrow Bio...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Dasatinib
Daunorubicin
Doxorubicin
Echocardiograph...
Leucovorin
Mercaptopurine
Methotrexate
Multigated Acqu...
Pegaspargase
Prednisolone
Prednisone
Radiation Thera...
Thioguanine
Vincristine
366 Days - 46 Years National Cancer Institute (NCI) View CalPeg for Newly Diagnosed Acute Lymphoblastic Leukemia (ALL) NCT05581030 Acute Lymphobla...
Hyper CVAD Prot...
Calaspargase Pe...
Rituximab
18 Years - 50 Years H. Lee Moffitt Cancer Center and Research Institute View Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy NCT03959085 B Acute Lymphob...
B Lymphoblastic...
Central Nervous...
Mixed Phenotype...
Testicular Leuk...
Biospecimen Col...
Bone Marrow Asp...
Bone Marrow Bio...
Bone Scan
Calaspargase Pe...
Computed Tomogr...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Doxorubicin Hyd...
Inotuzumab Ozog...
Leucovorin Calc...
Magnetic Resona...
Mercaptopurine
Methotrexate
Pegaspargase
Positron Emissi...
Prednisolone
Questionnaire A...
Radiation Thera...
Radiation Thera...
Thioguanine
Vincristine Sul...
1 Year - 25 Years Children's Oncology Group View Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax NCT05192889 Refractory Acut...
Relapsed Acute ...
Venetoclax
Navitoclax
Dexamethasone
Vincristine
Calaspargase Pe...
Dasatinib
Cytarabine
Blinatumomab
Methotrexate
Mercaptopurine
Cyclophosphamid...
Etoposide
Leucovorin
Intrathecal Tri...
Pegaspargase
Erwinia asparag...
Radiation
4 Years - 30 Years St. Jude Children's Research Hospital View A Study of SNDX-5613 in Combination With Chemotherapy for Patients Diagnosed With Relapsed or Refractory Leukemia NCT05761171 Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Acute...
Recurrent Mixed...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Acut...
Refractory Mixe...
Biospecimen Col...
Bone Marrow Asp...
Calaspargase Pe...
Cytarabine
Echocardiograph...
Fludarabine Pho...
Hydrocortisone ...
Lumbar Puncture
Methotrexate
Multigated Acqu...
Prednisolone
Prednisone
Revumenib
Vincristine Sul...
1 Month - 6 Years Children's Oncology Group View Trial Treating Relapsed Acute Lymphoblastic Leukemia With Venetoclax and Navitoclax NCT05192889 Refractory Acut...
Relapsed Acute ...
Venetoclax
Navitoclax
Dexamethasone
Vincristine
Calaspargase Pe...
Dasatinib
Cytarabine
Blinatumomab
Methotrexate
Mercaptopurine
Cyclophosphamid...
Etoposide
Leucovorin
Intrathecal Tri...
Pegaspargase
Erwinia asparag...
Radiation
4 Years - 30 Years St. Jude Children's Research Hospital View Venetoclax Basket Trial for High Risk Hematologic Malignancies NCT05292664 Myelodysplastic...
Myelodysplastic...
Myelodysplastic...
Treatment-Relat...
Therapy-Related...
Acute Lymphobla...
Acute Lymphobla...
Lymphoblastic L...
Lymphoblastic L...
Acute Leukemia ...
Acute Leukemia ...
Venetoclax
Azacitidine
Cytarabine
Methotrexate
Hydrocortisone
Leucovorin
Dexamethasone
Vincristine
Doxorubicin
Dexrazoxane
Calaspargase Pe...
Erwinia asparag...
1 Year - 40 Years Dana-Farber Cancer Institute View Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma NCT05602194 B Acute Lymphob...
B Acute Lymphob...
B Acute Lymphob...
Lymphoblastic L...
Mixed Phenotype...
T Acute Lymphob...
Biospecimen Col...
Calaspargase Pe...
Levocarnitine
Pegaspargase
Quality-of-Life...
15 Years - 40 Years Children's Oncology Group View Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia NCT03007147 Acute Lymphobla...
B Acute Lymphob...
Mixed Phenotype...
T Acute Lymphob...
Allogeneic Hema...
Calaspargase Pe...
Cyclophosphamid...
Cytarabine
Daunorubicin Hy...
Dexamethasone
Dexrazoxane Hyd...
Doxorubicin
Etoposide
Filgrastim
Ifosfamide
Imatinib Mesyla...
Laboratory Biom...
Leucovorin Calc...
Mercaptopurine
Mercaptopurine
Methotrexate
Methylprednisol...
Pegaspargase
Prednisolone
Questionnaire A...
Therapeutic Hyd...
Thioguanine
Vincristine Sul...
1 Year - 21 Years Children's Oncology Group View Calaspargase Pegol in Adults With ALL NCT04817761 Acute Lymphobla...
Calaspargase pe...
22 Years - 55 Years Servier View